FLUENT Corp.

US$0.01As of Sun 8 Nov 2026, 12:00 UTC
CSE:FNT-UHealthcare
Country Canada
PE (Fwd) •••
TSR 8Y CAGR (46.54%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.76
PE TTM —
TSR TTM (71.43%)
Mkt cap US$13.51M
ROIC (22.77%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0184
22.53%
(51.94%)
Hold 9|5|4|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
16.83%
18.34%
7.00%
12.66%
Revenue$M
1.053
1.062
1.078
1.049
9.49%
7.47%
6.33%
(0.11%)
Peers (US$13.51M)
Cap (US$)
PE
15.00M
4.459x
13.93M
18.09x
Capital
TTM
5Y
10Y
Leveragex
0.801
0.089
0.086
EBIT/Intx
2.452
0.112
0.136
Own earn%
(63.07)
58.72
59.02
Sh yield%
27.64
25.16
28.04
Owners
Insiders/Inst%
1.03
63.36
Short interest%
5.73
SBC / revenue%
4.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
10–15
$1 testx
—
Incr. ROIC%
7